About Medall
Medall is a company based in Chennai (India) founded in 2008. Medall has raised $55.1 million across 10 funding rounds from investors including Peepul Capital, Captain N Raghavan and Ajay Sakamuri. Medall operates in a competitive market with competitors including Thyrocare, Vijaya Diagnostic Centre, Suraksha Diagnostics, Igenetic and Krsnaa Diagnostics, among others.
- Headquarter Chennai, India
- Stage Minicorn
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
$19.78 M (USD)-20as on Mar 31, 2023
-
Net Profit
-$30.74 M (USD)-279as on Mar 31, 2023
-
EBITDA
-$18.64 M (USD)-2916as on Mar 31, 2023
-
Total Equity Funding
$55.1 M (USD)
in 10 rounds
-
Latest Funding Round
Not available
-
Investors
Peepul Capital
& 8 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
People of Medall
Unlock access to complete
Funding Insights of Medall
Medall has successfully raised a total of $55.1M across 10 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Medall
Medall has secured backing from 9 investors, including angel, venture fund, and institutional investors. Prominent investors backing the company include Peepul Capital, Captain N Raghavan and Ajay Sakamuri.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Private equity firm focused on buyouts
|
Locked | Locked | Locked | |
|
Private equity firm engaged in growth investments across India.
|
Locked | Locked | Locked | |
|
Venture capital firm investing in multiple sectors
|
Locked | Locked | Locked |
Investor details for Medall
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Medall
Investment portfolio details for Medall
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Medall
Detailed financials for Medall
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Medall Comparisons
Peer comparison for Medall
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Medall
Medall operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Thyrocare, Vijaya Diagnostic Centre, Suraksha Diagnostics, Igenetic and Krsnaa Diagnostics, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Diagnostic testing centers for pathology and health screenings are operated.
|
|
| Locked | Locked | Locked |
Diagnostic services are offered via a chain of centers.
|
|
| Locked | Locked | Locked |
Pathology, molecular diagnostics, and imaging services are provided.
|
|
| Locked | Locked | Locked |
Provider molecular diagnostic solutions and services
|
|
| Locked | Locked | Locked |
Chain of radiology & pathology laboratory centers
|
|
| Locked | Locked | Locked |
Chain of diagnostic centers
|
Detailed competitors of Medall
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Medall
Complete news archive for Medall
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Medall
Medall was founded in 2008 and raised its 1st funding round 1 year after it was founded.
Medall is headquartered in Chennai, India. It is registered at Chennai, Tamil Nadu, India.
Preetha Raja is the current CEO of Medall.
Medall is a funded company, having raised a total of $55.1M across 10 funding rounds to date.
Annual revenue of Medall is $19.78M as on Mar 31, 2023.
Medall was founded in 2008 in Chennai, India, as a chain of medical diagnostic service centres. Operations focus on healthcare diagnostics, with lab tests and radiology services including CT and MRI scans, ultrasound, X-rays, ECG, ECHO, TMT, and mammograms offered across facilities. The company serves the diagnostic sector primarily in India, supporting clinical assessments for patients.
Medall's top competitors include Thyrocare, Krsnaa Diagnostics and Suraksha Diagnostics.
Medall has 9 investors. Key investors include Peepul Capital, Captain N Raghavan, Ajay Sakamuri, Siguler Guff, and Palmyrah Capital.
The valuation of Medall is $39.03M as of Mar 2024.